TDOC

Teladoc Health Inc. (TDOC) | Rumor.io

Teladoc Health

TDOC

Attention (50-day avg)0.01%

Attention rank (50-day avg)#357

Bullish sentiment (50-day avg)50%

Price to earnings ratio-5.12

Market capitalization1.1B

Earnings per share-0.99

Dividend yield (TTM)—

Revenue (annual)2.5B

Net income (annual)-200.3M

Social

What share of all stock conversation is about TDOC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% +0	0% 0	0% -0.04	0.01% -0.01

Sep 29

$TDOC's stock price has been declining, but no reversal has been confirmed, with the next level to watch being $5.76.
Government funding for telemedicine and remote patient monitoring has been announced, which could be a positive external catalyst for Teladoc Health.
The company's Research & Development budget is around $270 million per year, and investors are questioning the value of this spending, with some suggesting that the leadership is incompetent.

Generated by AI

Sentiment

Of the messages about TDOC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0% -22.22	8.82% -49.07	59.44% +40.66	67.8% -2.77
Bearish	100% +22.22	91.18% +49.07	40.56% -40.66	32.2% +2.77

Bullish· Jul 30

Teladoc Health, Inc. is setting up for the future by adapting to changes to gain more subscribers and revenue, with its Betterhelp business now available in all 50 states.
The company's current revenue guidance issues are temporary and not a structural decline, with a potential revenue growth pivot late this year into next, driven by initiatives such as TelaDoc One.
Teladoc's valuation is undervalued, with the company worth at least $15 if it were to sell all or part of itself, and short interest is still hovering at all-time highs, offering a potential upside for investors.

Bearish· Aug 4

The CEO, Chuck Divita, has failed to predict and address the decline in revenue due to the shift in user behavior, specifically the increase in demand for insurance among BetterHelp users.
The company's management has been accused of manipulating the stock price and hiding issues such as the therapist bottleneck problem, with some shareholders suggesting that they prioritize their own paychecks over the company's well-being.
The company's valuation is considered disconnected from its fundamentals, with some investors arguing that it should be illegal to value a $3B revenue company with over $500B in cash and a positive EBITA of $300M with a market cap of less than 2 quarters' sales.

Generated by AI

Topics

Of the messages about TDOC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	32%	30.11%	4.01%
Technical Analysis	100%	68%	68.82%	40.1%
Macro	0%	0%	0%	50.97%
Earnings	0%	0%	0%	2.37%
Controversies	0%	0%	1.08%	0.06%
Analysts	0%	0%	0%	2.49%

Earnings· Feb 25

Teladoc Health ($TDOC) reported Q4 earnings that beat estimates, with revenue of $642.3M and adjusted EBITDA of $83.8M.
The company guided FY26 revenue of $2.47B to $2.59B and adjusted EBITDA of $266M to $308M.
Teladoc's Q4 net loss was $25.1M, but the company narrowed its net loss YoY, and its adjusted EBITDA improved 12% in Q4.

Analysts· Mar 10

Deutsche Bank upgraded Teladoc Health (TDOC) to Buy from Hold with a price target of $11, citing a "compelling" valuation and a deliverable strategy for the BetterHelp business.
The upgrade comes after Bank of America raised its price target on TDOC to $8.25, also citing the acquisition of Talkspace by Universal Health as a positive for Teladoc.
Analysts see a potential exit scenario for Teladoc, with a comparable transaction illustrating the road map as a path forward, and view the company's valuation as significantly mispriced at current levels.

Announcements· Mar 10

Deutsche Bank upgraded Teladoc Health to Buy from Hold with a price target of $11, citing compelling valuation and a deliverable strategy for the BetterHelp business.
Teladoc Health shares surged 10% pre-market after analyst calls valuation "compelling" post-Talkspace deal, with the stock eyeing its highest level since January 26.
Teladoc Health is expected to be a major beneficiary of federally funded rural healthcare contracts, with the first few states announcing award winners in early April.

Controversies· Jun 16

Teladoc Health, Inc. is facing a class action lawsuit due to a 40.15% stock loss, with investors accusing the company of securities violations.
Levi & Korsinsky has notified Teladoc Health, Inc. investors of a class action lawsuit and an upcoming deadline to file a claim.
Teladoc Health, Inc. has been issued a lawsuit alert by Levi & Korsinsky, citing securities law violations and a significant stock loss for investors.

Macro· Apr 30

Teladoc Health's business model has been questioned, with some investors doubting its profitability.
A potential global food crisis and pandemic could negatively impact stocks like BYND and TDOC, making them attractive for investors looking for a DIP.
Teladoc Health's massive amount of healthcare data is valuable, with the company owning a commodity that could increase in value as digital health records become more prevalent.

Technical Analysis· Feb 21

$TDOC is trading in a downtrend, with a weekly "death candle" in April 2022 indicating a significant price drop.
The stock is testing the lower end of its weekly demand zone, with support at $15.9X and a potential next down target between $12.50 and $9.50.
$TDOC's 50-moving average has historically served as both support and resistance, and a break above this level is necessary for further bullish upside.

Generated by AI

Community

Of the messages about TDOC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	96.43%	83.33%	66.24%	46.49%
Newcomers	3.57%	16.67%	33.76%	53.51%

Regulars· Sep 29

The stock price of $TDOC continues to decline, and there's no clear indication of a reversal, with the next level to watch being $5.76.
Government funding for telemedicine and remote patient monitoring, as seen in recent CMS and Texas deployments, validates the market for distributed care, chronic care, and RPM, areas where Teladoc/Integrated Care/Teladoc One could participate.
The recent HHS Secretary's vision to connect medical and lifestyle data across CMS, CDC, and FDA, and use AI to identify chronic-disease patterns, closely resembles the infrastructure behind Teladoc One and Pulse, but requires further confirmation through formal initiatives or partnerships.

Newcomers· Aug 25

Newcomers are noting that Teladoc Health, Inc. (TDOC) has seen significant declines in value, with the stock down 87-97% from its highs.
They are highlighting that in the same 9-week window in 2021, YoY revenue growth for TDOC came in lower than the quarter before, indicating a deceleration in growth.
The focus is on the company's financial filings, specifically the writing off of $13.4 billion in goodwill, which has raised concerns among investors and newcomers.

Generated by AI

News

Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Teladoc (TDOC) reached $5.75 at the closing of the latest trading day, reflecting a -2.38% change compared to its last close.

14h agoYahoo Finance Singapore

Reddit and Teladoc Shares Plummet, What You Need To Know

A number of stocks fell in the afternoon session after the benchmark U.S. 10-year Treasury yield climbed back above 5% to levels not seen since 2007, lifting discount rates on long-duration growth earnings. According to CNBC, the 10-year yield surged to 5.23% on Friday, its highest level since 2007, after trading below 4.8% earlier in September. CNBC reported Monday that the yield was again pressing multiyear highs — above 5.23% in morning trade — as oil stayed elevated and investors braced for

1d agoYahoo Finance

Reddit and Teladoc Shares Plummet, What You Need To Know

Detailed price information for Teladoc Health Inc (TDOC-N) from The Globe and Mail including charting and trades.

1d agoThe Globe and Mail

Why is Teladoc stock sliding today?

1d agoInvesting.com

Teladoc Health announces resignation of chief legal officer, names successor

4d agoInvesting.com

Teladoc Health Announces Chief Legal Officer Transition

Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026 Jonathan Dorfman Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026. NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with the company, Adam Vandervoort, Chief Legal Officer and Secretary, has informed the company o

4d agoYahoo Finance

Also Discussed

Investors talking about TDOC also mention

#	Name	Attention
1	American Well Corporation Class A Common StockAMWL	0%+0
2	ONEM - 1Life Healthcare, Inc.	——
3	Zoom Communications, Inc. Class A Common StockZM	0%+0
4	Roku, Inc. Class A Common StockROKU	0%new
5	ARK Innovation ETF FundARKK	0%-0.13
6	Fastly, Inc.FSLY	0.01%0
7	Twilio Inc. Class A Common StockTWLO	0%-0.06
8	Doximity Inc. Class A Common StockDOCS	0%0
9	DocuSign Inc.DOCU	0%new
10	Pinterest, Inc. Class APINS	0%0

Teladoc Health Inc.

Healthcare
Health Information Services

Teladoc Health Inc. is a virtual healthcare company that provides technology-enabled medical services for patients, employers, health plans, hospitals, and health systems. Its platform supports remote access to general medical care, mental health services, chronic condition management, specialty consultations, and expert medical opinions through phone, video, mobile, and web-based channels. The company operates through two main business segments: Integrated Care, which delivers enterprise virtual care solutions, and BetterHelp, a direct-to-consumer online mental health platform. Teladoc Health Inc. plays a significant role in the digital health market by connecting clinicians and care seekers through scalable, on-demand care delivery across a broad range of healthcare needs.

Website

Location

155 E 44th Street

New York, NY, 10017

United States

Social

What share of all stock conversation is about TDOC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% +0	0% 0	0% -0.04	0.01% -0.01

Sep 29

$TDOC's stock price has been declining, but no reversal has been confirmed, with the next level to watch being $5.76.
Government funding for telemedicine and remote patient monitoring has been announced, which could be a positive external catalyst for Teladoc Health.
The company's Research & Development budget is around $270 million per year, and investors are questioning the value of this spending, with some suggesting that the leadership is incompetent.

Generated by AI

Sentiment

Of the messages about TDOC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0% -22.22	8.82% -49.07	59.44% +40.66	67.8% -2.77
Bearish	100% +22.22	91.18% +49.07	40.56% -40.66	32.2% +2.77

Bullish· Jul 30

Teladoc Health, Inc. is setting up for the future by adapting to changes to gain more subscribers and revenue, with its Betterhelp business now available in all 50 states.
The company's current revenue guidance issues are temporary and not a structural decline, with a potential revenue growth pivot late this year into next, driven by initiatives such as TelaDoc One.
Teladoc's valuation is undervalued, with the company worth at least $15 if it were to sell all or part of itself, and short interest is still hovering at all-time highs, offering a potential upside for investors.

Bearish· Aug 4

The CEO, Chuck Divita, has failed to predict and address the decline in revenue due to the shift in user behavior, specifically the increase in demand for insurance among BetterHelp users.
The company's management has been accused of manipulating the stock price and hiding issues such as the therapist bottleneck problem, with some shareholders suggesting that they prioritize their own paychecks over the company's well-being.
The company's valuation is considered disconnected from its fundamentals, with some investors arguing that it should be illegal to value a $3B revenue company with over $500B in cash and a positive EBITA of $300M with a market cap of less than 2 quarters' sales.

Generated by AI

Topics

Of the messages about TDOC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	32%	30.11%	4.01%
Technical Analysis	100%	68%	68.82%	40.1%
Macro	0%	0%	0%	50.97%
Earnings	0%	0%	0%	2.37%
Controversies	0%	0%	1.08%	0.06%
Analysts	0%	0%	0%	2.49%

Earnings· Feb 25

Teladoc Health ($TDOC) reported Q4 earnings that beat estimates, with revenue of $642.3M and adjusted EBITDA of $83.8M.
The company guided FY26 revenue of $2.47B to $2.59B and adjusted EBITDA of $266M to $308M.
Teladoc's Q4 net loss was $25.1M, but the company narrowed its net loss YoY, and its adjusted EBITDA improved 12% in Q4.

Analysts· Mar 10

Deutsche Bank upgraded Teladoc Health (TDOC) to Buy from Hold with a price target of $11, citing a "compelling" valuation and a deliverable strategy for the BetterHelp business.
The upgrade comes after Bank of America raised its price target on TDOC to $8.25, also citing the acquisition of Talkspace by Universal Health as a positive for Teladoc.
Analysts see a potential exit scenario for Teladoc, with a comparable transaction illustrating the road map as a path forward, and view the company's valuation as significantly mispriced at current levels.

Announcements· Mar 10

Deutsche Bank upgraded Teladoc Health to Buy from Hold with a price target of $11, citing compelling valuation and a deliverable strategy for the BetterHelp business.
Teladoc Health shares surged 10% pre-market after analyst calls valuation "compelling" post-Talkspace deal, with the stock eyeing its highest level since January 26.
Teladoc Health is expected to be a major beneficiary of federally funded rural healthcare contracts, with the first few states announcing award winners in early April.

Controversies· Jun 16

Teladoc Health, Inc. is facing a class action lawsuit due to a 40.15% stock loss, with investors accusing the company of securities violations.
Levi & Korsinsky has notified Teladoc Health, Inc. investors of a class action lawsuit and an upcoming deadline to file a claim.
Teladoc Health, Inc. has been issued a lawsuit alert by Levi & Korsinsky, citing securities law violations and a significant stock loss for investors.

Macro· Apr 30

Teladoc Health's business model has been questioned, with some investors doubting its profitability.
A potential global food crisis and pandemic could negatively impact stocks like BYND and TDOC, making them attractive for investors looking for a DIP.
Teladoc Health's massive amount of healthcare data is valuable, with the company owning a commodity that could increase in value as digital health records become more prevalent.

Technical Analysis· Feb 21

$TDOC is trading in a downtrend, with a weekly "death candle" in April 2022 indicating a significant price drop.
The stock is testing the lower end of its weekly demand zone, with support at $15.9X and a potential next down target between $12.50 and $9.50.
$TDOC's 50-moving average has historically served as both support and resistance, and a break above this level is necessary for further bullish upside.

Generated by AI

Community

Of the messages about TDOC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	96.43%	83.33%	66.24%	46.49%
Newcomers	3.57%	16.67%	33.76%	53.51%

Regulars· Sep 29

The stock price of $TDOC continues to decline, and there's no clear indication of a reversal, with the next level to watch being $5.76.
Government funding for telemedicine and remote patient monitoring, as seen in recent CMS and Texas deployments, validates the market for distributed care, chronic care, and RPM, areas where Teladoc/Integrated Care/Teladoc One could participate.
The recent HHS Secretary's vision to connect medical and lifestyle data across CMS, CDC, and FDA, and use AI to identify chronic-disease patterns, closely resembles the infrastructure behind Teladoc One and Pulse, but requires further confirmation through formal initiatives or partnerships.

Newcomers· Aug 25

Newcomers are noting that Teladoc Health, Inc. (TDOC) has seen significant declines in value, with the stock down 87-97% from its highs.
They are highlighting that in the same 9-week window in 2021, YoY revenue growth for TDOC came in lower than the quarter before, indicating a deceleration in growth.
The focus is on the company's financial filings, specifically the writing off of $13.4 billion in goodwill, which has raised concerns among investors and newcomers.

Generated by AI

Teladoc Health

Social

Sep 29

Bullish· Jul 30

Bearish· Aug 4

Earnings· Feb 25

Analysts· Mar 10

Announcements· Mar 10

Controversies· Jun 16

Macro· Apr 30

Technical Analysis· Feb 21

Regulars· Sep 29

Newcomers· Aug 25

Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Reddit and Teladoc Shares Plummet, What You Need To Know

Reddit and Teladoc Shares Plummet, What You Need To Know

Why is Teladoc stock sliding today?

Teladoc Health announces resignation of chief legal officer, names successor

Teladoc Health Announces Chief Legal Officer Transition

Also Discussed

Teladoc Health Inc.

Company Information

Location

Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Reddit and Teladoc Shares Plummet, What You Need To Know

Reddit and Teladoc Shares Plummet, What You Need To Know

Why is Teladoc stock sliding today?

Teladoc Health announces resignation of chief legal officer, names successor

Teladoc Health Announces Chief Legal Officer Transition

Also Discussed

Social

Sep 29

Bullish· Jul 30

Bearish· Aug 4

Earnings· Feb 25

Analysts· Mar 10

Announcements· Mar 10

Controversies· Jun 16

Macro· Apr 30

Technical Analysis· Feb 21

Regulars· Sep 29

Newcomers· Aug 25